Clinical question comments:Is there any survival advantage for androgen blockade (androgen ablation, deprivation) when used as first line therapy in the adjuvant or neoadjuvant setting with radiotherapy for loca/Recommendations

General information on how to comment

• If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
• Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence.

How to post a public comment

1. Create a user account and/or log in with your details
2. To post a comment, click the blue 'Make a new comment' link below
   
3. Fill in the empty boxes

   Warning: You need to fill out the subject line and box!

4. Attach supporting references and any new papers to go with your comment and to be considered by the author group for inclusion by clicking on "Attach academic evidence".
5. Press 'save page' to post your comment!
   

In order to leave a comment, you must be logged into a Cancer Council Australia account.
Log in to your account Create your account